Nautilus Biotechnology, Inc.

General ticker "NAUT" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $273.2M (TTM average)

Nautilus Biotechnology, Inc. follows the US Stock Market performance with the rate: 9.3%.

Estimated limits based on current volatility of 6.1%: low 0.72$, high 0.81$

Factors to consider:

  • Earnings expected soon, date: 2025-04-29 bmo
  • Current price 40.7% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.21$, 2.81$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.21$, 2.76$]

Financial Metrics affecting the NAUT estimates:

  • Negative: Non-GAAP EPS, $ of -0.56 <= 0.04
  • Negative: Operating cash flow per share per price, % of -18.92 <= 1.79
  • Negative: Industry operating cash flow per share per price (median), % of 0.98 <= 2.82
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: -0.07 < Operating profit margin, % of 0
  • Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of 0
  • Positive: Shareholder equity ratio, % of 85.99 > 63.75

Similar symbols

Short-term NAUT quotes

2025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-210.70.80.911.11.21.3
Price $

Long-term NAUT plot with estimates

0.511.522.533.544.5Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.15−0.1−0.050
NAUTS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $63.62MM $76.15MM $0.00MM
Operating Income $-63.62MM $-76.15MM $0.00MM
Non-Operating Income $5.69MM $12.48MM $-70.78MM
Interest Expense $5.82MM $0.00MM $0.00MM
R&D Expense $37.67MM $47.25MM $50.48MM
Income(Loss) $-57.92MM $-63.67MM $-70.78MM
Profit(Loss)* $-57.92MM $-63.67MM $-70.78MM
Stockholders Equity $314.92MM $265.35MM $208.73MM
Assets $350.05MM $305.56MM $242.74MM
Operating Cash Flow $-45.81MM $-51.71MM $-59.15MM
Capital expenditure $2.32MM $2.44MM $2.12MM
Investing Cash Flow $-25.74MM $-43.73MM $66.25MM
Financing Cash Flow $0.56MM $0.37MM $1.14MM
Earnings Per Share** $-0.46 $-0.51 $-0.56

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.